Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN
Open Access
- 4 March 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (9) , 1765-1769
- https://doi.org/10.1038/sj.onc.1202492
Abstract
PTEN/MMAC1 is a recently characterized tumor suppressor. A pseudogene derived from the human PTEN/MMAC1 phosphatase, ΨPTEN, has been reported. Recent analysis of the pseudogene revealed conflicting results about the expression of ΨPTEN. In this study, we show that the PTEN/MMAC1 pseudogene is actively transcribed in all cells and tissues examined. In some cases, pseudogene transcripts were found to represent as much as 70% of the total PTEN/MMAC1 RNA. As ΨPTEN is transcribed, there is a potential for misinterpretation of PTEN/MMAC1 mutations when RT – PCR techniques are used, as well as potential for a ΨPTEN-encoded translation product. Although we were unable to detect a pseudogene protein product in the cell lines examined, a baculovirus produced GST pseudogene fusion protein exhibited phosphatase activity comparable to wild type. The results of this study, taken together, indicate the potential complication of PTEN/MMAC1 molecular analysis caused by the expression of ΨPTEN.Keywords
This publication has 17 references indexed in Scilit:
- A highly conserved processed PTEN pseudogene is located on chromosome band 9p21Oncogene, 1998
- Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell linesOncogene, 1998
- Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domainProceedings of the National Academy of Sciences, 1997
- Germline mutations in PTEN are present in Bannayan-Zonana syndromeNature Genetics, 1997
- Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndromeNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursNature Genetics, 1995
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Organization of human T-cell receptor beta-chain genes: clusters of V beta genes are present on chromosomes 7 and 9.Proceedings of the National Academy of Sciences, 1993